{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:55:38Z","timestamp":1760576138150,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.ejpb.2010.09.006","type":"journal-article","created":{"date-parts":[[2010,9,19]],"date-time":"2010-09-19T04:14:11Z","timestamp":1284869651000},"page":"357-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Differences between reversible (self-association) and irreversible aggregation of rHuG-CSF in carbohydrate and polyol formulations"],"prefix":"10.1016","volume":"76","author":[{"given":"Renata","family":"Pavi\u0161i\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Dodig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Horvati\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucija","family":"Miji\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirela","family":"Sedi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0161a Raji\u0107","family":"Linari\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ita Grui\u0107","family":"Sovulj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tajana","family":"Preo\u010danin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana Bukvi\u0107","family":"Kraja\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Cindri\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2010.09.006_b0005","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejpb.2010.09.006_b0010","doi-asserted-by":"crossref","first-page":"E572","DOI":"10.1208\/aapsj080366","article-title":"Protein aggregation and bioprocessing","volume":"8","author":"Cromwell","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2010.09.006_b0015","doi-asserted-by":"crossref","first-page":"10855","DOI":"10.1074\/jbc.M804813200","article-title":"Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells","volume":"284","author":"Ratovitski","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2010.09.006_b0020","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1016\/S0006-3495(96)79859-4","article-title":"Simulations of reversible protein aggregate and crystal structure","volume":"70","author":"Patro","year":"1996","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejpb.2010.09.006_b0025","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1023\/A:1025771421906","article-title":"Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation","volume":"20","author":"Chi","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2010.09.006_b0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpharm.2009.12.015","article-title":"Recombinant human granulocyte colony stimulating factor pre-screening and screening of stabilizing carbohydrates and polyols","volume":"387","author":"Pavi\u0161i\u0107","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2010.09.006_b0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ejpb.2008.09.012","article-title":"Role of benzyl alcohol in the prevention of heat-induced aggregation and inactivation of hen egg white lysozyme","volume":"71","author":"Goyal","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2010.09.006_b0040","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/jps.21955","article-title":"High throughput thermostability screening of monoclonal antibody formulations","volume":"99","author":"He","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2010.09.006_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4615-0557-0_1","article-title":"Practical approaches to protein formulation development","volume":"13","author":"Chang","year":"2002","journal-title":"Pharm. Biotechnol."},{"key":"10.1016\/j.ejpb.2010.09.006_b0050","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4161\/mabs.1.3.8035","article-title":"Potential aggregation prone regions in biotherapeutics: a survey of commercial monoclonal antibodies","volume":"1","author":"Wang","year":"2009","journal-title":"MAbs"},{"key":"10.1016\/j.ejpb.2010.09.006_b0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2478\/v10007-008-0003-6","article-title":"Studying the formation of aggregates in recombinant human granulocyte-colony stimulating factor (rHuG-CSF), lenograstim, using size-exclusion chromatography and SDS\u2013PAGE","volume":"58","author":"Ribarska","year":"2008","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejpb.2010.09.006_b0060","series-title":"Formulation, Characterisation and Stability of Protein Drugs","first-page":"303","article-title":"Characterization, formulation, and stability of Neupogen\u00ae (Filgrastim) a recombinant human granulocyte colony stimulating factor","author":"Herman","year":"1996"},{"key":"10.1016\/j.ejpb.2010.09.006_b0065","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/jps.20619","article-title":"Effects of pH, temperature, and sucrose on benzyl alcohol-induced aggregation of recombinant human granulocyte colony stimulating factor","volume":"95","author":"Thirumangalathu","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2010.09.006_b0070","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1073\/pnas.90.11.5167","article-title":"The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors","volume":"90","author":"Hill","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejpb.2010.09.006_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.11.014","article-title":"Protein aggregation and its inhibition in biopharmaceutics","volume":"289","author":"Wang","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2010.09.006_b0080","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0006-3495(00)76602-1","article-title":"The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein","volume":"78","author":"Vermeer","year":"2000","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejpb.2010.09.006_b0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0040-6031(94)01892-K","article-title":"Thermal analysis of proteins of pharmaceutical interest","volume":"248","author":"Chen","year":"1995","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.ejpb.2010.09.006_b0090","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1021\/js9801384","article-title":"Aggregation of recombinant human interferon gamma: kinetics and structural transitions","volume":"87","author":"Kendrick","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2010.09.006_b0095","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10973-007-8574-x","article-title":"The effect of glucose on bovine serum albumin denatured aggregation kinetics at high concentration: the master plots method study by DSC","volume":"93","author":"Cao","year":"2008","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.ejpb.2010.09.006_b0100","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0006-3495(92)81899-4","article-title":"Theoretical analysis of Lumry\u2013Eyring models in differential scanning calorimetry","volume":"61","author":"Sanchez-Ruiz","year":"1992","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejpb.2010.09.006_b0105","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1016\/S0006-3495(03)75122-4","article-title":"Protein self-association in solution: the bovine pancreatic trypsin inhibitor decamer","volume":"84","author":"Gottschalk","year":"2003","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejpb.2010.09.006_b0110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bpc.2009.09.001","article-title":"Direct allowance for the effects of thermodynamic nonideality in the quantitative characterization of protein self-association by osmometry","volume":"145","author":"Wills","year":"2009","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.ejpb.2010.09.006_b0115","doi-asserted-by":"crossref","DOI":"10.2174\/138920109788488923","article-title":"Aggregation detection and removal biopharmaceutical proteins","volume":"10","author":"Gagnon","year":"2009","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ejpb.2010.09.006_b0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ab.2009.09.036","article-title":"Precision of protein aggregation measurements by sedimentation velocity analytical ultracentrifugation in biopharmaceutical applications","volume":"396","author":"Gabrielson","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejpb.2010.09.006_b0125","doi-asserted-by":"crossref","first-page":"E580","DOI":"10.1208\/aapsj080367","article-title":"A critical review of analytical ultracentrifugation and field flow fractionation methods for measuring protein aggregation","volume":"8","author":"Liu","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2010.09.006_b0130","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/bi00405a039","article-title":"Differential scanning calorimetry of the irreversible thermal denaturation of thermolysin","volume":"27","author":"Sanchez-Ruiz","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejpb.2010.09.006_b0135","first-page":"42","article-title":"Aggregation analysis of therapeutic proteins, Part 1: general aspects and techniques for assessment","volume":"4","author":"Arakawa","year":"2006","journal-title":"BioProcess Int."},{"key":"10.1016\/j.ejpb.2010.09.006_b0140","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1021\/bp034120x","article-title":"Determination of size distribution and encapsulation efficiency of liposome-encapsulated hemoglobin blood substitutes using asymmetric flow field-flow fractionation coupled with multi-angle static light scattering","volume":"19","author":"Arifin","year":"2003","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.ejpb.2010.09.006_b0145","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/jps.21869","article-title":"Multi-variate approach to global protein aggregation behavior and kinetics: effects of pH NaCl and temperature for alpha-chymotrypsinogen A","volume":"99","author":"Li","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2010.09.006_b0150","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1351\/pac200173040745","article-title":"Measurement and analysis of results obtained on biological substances with differential scanning calorimetry","volume":"73","author":"Hinz","year":"2001","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.ejpb.2010.09.006_b0155","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.1021\/bi7005515","article-title":"Quantitative characterization of weak self-association in concentrated solutions of immunoglobulin G via the measurement of sedimentation equilibrium and osmotic pressure","volume":"46","author":"Jimenez","year":"2007","journal-title":"Biochemistry"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641110002286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641110002286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:28:50Z","timestamp":1760545730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641110002286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0939641110002286"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2010.09.006","relation":{},"ISSN":["0939-6411"],"issn-type":[{"type":"print","value":"0939-6411"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences between reversible (self-association) and irreversible aggregation of rHuG-CSF in carbohydrate and polyol formulations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2010.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}